Literature DB >> 7600298

Cloning from purified high endothelial venule cells of hevin, a close relative of the antiadhesive extracellular matrix protein SPARC.

J P Girard1, T A Springer.   

Abstract

High endothelial venules (HEV) in lymphoid tissues support high levels of lymphocyte extravasion from the blood. We purified high endothelial cells from human tonsils by immunomagnetic selection with MECA-79 MAb to construct an HEV cDNA library. Differential screening of this library using cDNA probes from HEV (plus) or flat-walled vessel (minus) endothelial cells allowed us to characterize a novel human cDNA expressed to high levels in HEV. The cDNA encodes a secreted acidic calcium-binding glycoprotein of 664 aa residues, designated hevin, exhibiting 62% identity with the antiadhesive extracellular matrix protein SPARC, over a region of 232 aa spanning more than four fifths of the SPARC coding sequence. The primary structure and sequence of hevin and similar to SPARC-like proteins from rat and quail, called SC1 or QR1. Hevin could contribute to the induction or maintenance of features of the HEV endothelium that facilitate lymphocyte migration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7600298     DOI: 10.1016/1074-7613(95)90083-7

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  41 in total

1.  Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules.

Authors:  Espen S Baekkevold; Myriam Roussigné; Takeshi Yamanaka; Finn-Eirik Johansen; Frode L Jahnsen; François Amalric; Per Brandtzaeg; Monique Erard; Guttorm Haraldsen; Jean-Philippe Girard
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

2.  CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.

Authors:  P Nair; R Melarkode; D Rajkumar; E Montero
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

3.  Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization.

Authors:  J P Girard; E S Baekkevold; T Yamanaka; G Haraldsen; P Brandtzaeg; F Amalric
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

4.  Matricellular homologs in the foreign body response: hevin suppresses inflammation, but hevin and SPARC together diminish angiogenesis.

Authors:  Thomas H Barker; Paul Framson; Pauli A Puolakkainen; May Reed; Sarah E Funk; E Helene Sage
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

5.  Localization of the extracellular matrix protein SC1 to synapses in the adult rat brain.

Authors:  Starlee Lively; Maurice J Ringuette; Ian R Brown
Journal:  Neurochem Res       Date:  2006-12-07       Impact factor: 3.996

6.  Mineralized tissue and vertebrate evolution: the secretory calcium-binding phosphoprotein gene cluster.

Authors:  Kazuhiko Kawasaki; Kenneth M Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-19       Impact factor: 11.205

7.  Localization of the extracellular matrix protein SC1 coincides with synaptogenesis during rat postnatal development.

Authors:  Starlee Lively; Ian R Brown
Journal:  Neurochem Res       Date:  2008-03-12       Impact factor: 3.996

8.  Dry eye and designer ophthalmics.

Authors:  Gordon W Laurie; Leslie A Olsakovsky; Brian P Conway; Robert L McKown; Kazuko Kitagawa; Jason J Nichols
Journal:  Optom Vis Sci       Date:  2008-08       Impact factor: 1.973

Review 9.  HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes.

Authors:  Jean-Philippe Girard; Christine Moussion; Reinhold Förster
Journal:  Nat Rev Immunol       Date:  2012-09-28       Impact factor: 53.106

10.  Processing of the matricellular protein hevin in mouse brain is dependent on ADAMTS4.

Authors:  Matt S Weaver; Gail Workman; Marina Cardo-Vila; Wadih Arap; Renata Pasqualini; E Helene Sage
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.